About this journal
Aims and scope
Ultrastructural Pathology is the official journal of the Society for Ultrastructural Pathology. Published bimonthly, we are the only journal to be devoted entirely to diagnostic ultrastructural pathology.
Ultrastructural Pathology is the ideal journal to publish high-quality research on the following topics:
- Advances in the uses of electron microscopic and immunohistochemical techniques
- Correlations of ultrastructural data with light microscopy, histochemistry, immunohistochemistry, biochemistry, cell and tissue culturing, and electron probe analysis
- Important new, investigative, clinical, and diagnostic EM methods
We welcome you to contribute to the journal to uphold our efforts to ensure Ultrastructural Pathology is the real voice of those actively engaged in providing ultrastructural support in diagnostic and experimental fields.
Editor-in-Chief, Dr Guillermo Herrera, leads an expert editorial board who are very sensitive to the need to provide proper, comprehensive, and timely feedback to all authors.Journal metrics
Usage
- 35K annual downloads/views
Citation metrics
- 1.1 (2023) Impact Factor
- 1.2 (2023) 5 year IF
- 2.0 (2023) CiteScore (Scopus)
- 0.339 (2023) SNIP
- 0.277 (2023) SJR
Speed/acceptance
- 1 days avg. from submission to first decision
- 28 days avg. from submission to first post-review decision
- 12 days avg. from acceptance to online publication
- 41% acceptance rate
Understanding and using journal metrics
Journal metrics can be a useful tool for readers, as well as for authors who are deciding where to submit their next manuscript for publication. However, any one metric only tells a part of the story of a journal’s quality and impact. Each metric has its limitations which means that it should never be considered in isolation, and metrics should be used to support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside other qualitative factors such as a journal’s aims & scope, its readership, and a review of past content published in the journal. In addition, a single article should always be assessed on its own merits and never based on the metrics of the journal it was published in.
For more details, please read the Author Services guide to understanding journal metrics.
Journal metrics in brief
Usage and acceptance rate data above are for the last full calendar year and are updated annually in February. Speed data is updated every six months, based on the prior six months. Citation metrics are updated annually mid-year. Please note that some journals do not display all of the following metrics (find out why).
- Usage: the total number of times articles in the journal were viewed by users of Taylor & Francis Online in the previous calendar year, rounded to the nearest thousand.
Citation Metrics
- Impact Factor*: the average number of citations received by articles published in the journal within a two-year window. Only journals in the Clarivate Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts and Humanities Citation Index (AHCI) and the Emerging Sources Citation Index (ESCI) have an Impact Factor.
- Impact Factor Best Quartile*: the journal’s highest subject category ranking in the Journal Citation Reports. Q1 = 25% of journals with the highest Impact Factors.
- 5 Year Impact Factor*: the average number of citations received by articles in the journal within a five-year window.
- CiteScore (Scopus)†: the average number of citations received by articles in the journal over a four-year period.
- CiteScore Best Quartile†: the journal’s highest CiteScore ranking in a Scopus subject category. Q1 = 25% of journals with the highest CiteScores.
- SNIP (Source Normalized Impact per Paper): the number of citations per paper in the journal, divided by citation potential in the field.
- SJR (Scimago Journal Rank): Average number of (weighted) citations in one year, divided by the number of articles published in the journal in the previous three years.
Speed/acceptance
- From submission to first decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision. Based on manuscripts receiving a first decision in the last six months.
- From submission to first post-review decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision if it is sent out for peer review. Based on manuscripts receiving a post-review first decision in the last six months.
- From acceptance to online publication: the average (median) number of days from acceptance of a manuscript to online publication of the Version of Record. Based on articles published in the last six months.
- Acceptance rate: articles accepted for publication by the journal in the previous calendar year as percentage of all papers receiving a final decision.
For more details on the data above, please read the Author Services guide to understanding journal metrics.
*Copyright: Journal Citation Reports®, Clarivate Analytics
†Copyright: CiteScore™, Scopus
Editorial board
Editor-in-Chief
Prof. Guillermo A. Herrera, MD
University of South Alabama
2451 USA Medical Center Drive
Department of Pathology
Mobile, AL 36617 USA
Associate Editors
Dr. John Hicks
Department of Pathology
Texas Children's Hospital and Baylor College of Medicine
6621 Fannin St, AB1195
Houston, Tx 77030
Fax: 832-825-1032
Phone; 832-824-2250 or 1869
[email protected]
Dr. Josep Lloreta Trull, MD
Department of Pathology
University Hospital del Mar
Passeig Maritim 25
08003 Barcelona, Spain
Phone: 34 93 221 1369
Fax: 34 93 221 0541
[email protected]
Dr. Elba A. Turbat-Herrera, MD
University of South Alabama
2451 USA Medical Center Drive
Department of Pathology
Mobile, AL 36617 USA
[email protected]
Editorial Board
Meenakshi Bhattacharjee - McGovern Medical School, The University of Texas Health Science Center, Houston,Texas, USA
Giovanna Cenacchi - Univresity of Bologna, Bologna, Italy
Patricia Chevez - Barrios - Houston Methodist, Texas Medical Center, Houston, Texas, USA
Giovanna Crisi - Baystate Pathology, Amherst, Massachusetts, USA
Hugo Dominguez-Malagon - Instituto Nacional de Cancerología, Mexico City, Mexico
Lillian Gaber - Houston Methodist Hospital, Houston,Texas, USA
Jacques Gilloteaux - Université de Namur, Namur, Belgium
Xin Gu - LSU Health Shreveport, Shreveport, Louisana, USA
Brent Harris - Georgetown University Medical Center, Washington, DC, USA
David Howell - Duke University, Durham, North Carolina, USA
Kyriacou Kyriacou - The Cyprus Institute of Neurology & Genetics, Cyprus
Ann Lefurgey - Duke University, Durham, North Carolina, USA
Soheir Mansy - Theodor Bilharz Research institute (TBRI), Guiza, Egypt
Kevin McCarthy - LSU Health Shreveport, Shreveport, Louisana, USA
Sara Miller - Duke University, Durham, North Carolina, USA
Volker Nickeleit - UNC School of Medicine, Chapel Hill, North Carolina, USA
Maria Picken - Loyola Medicine, Maywood, Illnois, USA
Zhang Ping - Beaumont Hospital, Royal Oak, Michigan, USA
Suzanne Powell - Houston Methodist Hospital, Houston,Texas, USA
Etheresia Pretorius - Stellenbosch University, South Africa
Victor Roggli - Duke University, Durham, North Carolina, USA
Josef Schroeder - Universität Regensburg, Germany
John Shelburne - Duke University, Durham, North Carolina, USA
Harsharan Singh - University of North Carolina, Chapel Hill, North Carolina, USA
Luan Truong - Houston Methodist Hospital, Houston, Texas, USA
Eric Wartchow - Children's Hospital Colorado, Aurora, Colorado, USA
Editorial Administrative Office
Jacinta Watkins - University of South Alabama, Alabama, USA
Abstracting and indexing
• EBSCOhost
• BIOBASE
• EMBASE
• Scopus, 1980-ongoing
• International Atomic Energy Agency; INIS Collection Search (International Nuclear Information System)
• MetaPress
• National Library of Medicine; PubMed/MEDLINE
• OCLC
• Personal Alert (E-mail)
• Thomson Reuters; Biological Abstracts (Online), BIOSIS Previews, Current Contents, Science Citation Index Expanded, Web of Science
Open access
Ultrastructural Pathology is a hybrid open access journal that is part of our Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
- Increase the discoverability and readership of your article
- Make an impact and reach new readers, not just those with easy access to a research library
- Freely share your work with anyone, anywhere
- Comply with funding mandates and meet the requirements of your institution, employer or funder
- Rigorous peer review for every open access article
Article Publishing Charges (APC)
If you choose to publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis.
Use our APC finder to calculate your article publishing charge
Society information
Official journal of the Society for Ultrastructural Pathology
The Society for Ultrastructural Pathology is an international association of electron microscopists, formed in 1986. The academic objectives of the Society are accomplished at the Companion Meeting of the annual United States and Canadian Academy of Pathology meeting and at the biennial Ultrapath conferences. The Society fosters the application of electron microscopy in the diagnosis and research of human diseases. The meetings are an opportunity for the exchange of information, particularly ultrastructural and immunohistochemical, relevant to diagnostic pathology. Members of the Society welcome practitioners of, and those who are interested in, the art and science of electron microscopy. This includes pathologists, residents and registrars in pathology, Ph.D. electron microscopists, electron microscopy technologists, and research scientists.
6 issues per year
Advertising information
Would you like to advertise in Ultrastructural Pathology?
Reach an engaged target audience and position your brand alongside authoritative peer-reviewed research by advertising in Ultrastructural Pathology.
Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors, make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .
Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site (link opens in a new window) Instructions for authors